On the Brink of Change–Congress Passes Patent Reform

AI News Roundup – Google unveils next-gen AI tools, controversy over U.K. scraping rules for AI training, Nvidia investing in AI-driven cars in China, and more

MBHB Partners Mike Borella and Joshua Rich discuss OpenAI’s stance on patents in Law360

AI News Roundup – U.S. announces further Chinese AI chip restrictions, Google’s AI weather prediction model, Trump names AI czar, and more

About the Authors

Kevin E. Noonan

Kevin E. Noonan is co-Chair of MBHB’s Biotechnology and Pharmaceuticals Practice Group. Dr. Noonan is an experienced patent lawyer, molecular biologist and renowned thought leader in biotechnology and pharmaceutical patent law. Over the past 30 years, he has counseled some of the largest biotechnology and pharmaceutical companies in the world on intellectual property issues.

Donald L. Zuhn, Jr.

Donald L. Zuhn, Jr. is a partner with McDonnell Boehnen Hulbert & Berghoff LLP and serves as Chair of the firm's Biotechnology & Pharmaceuticals Practice Group. Dr. Zuhn has more than a decade of experience in all aspects of patent prosecution, litigation, counseling, and licensing.

© 2024 McDonnell Boehnen Hulbert & Berghoff LLP snippets is a trademark of McDonnell Boehnen Hulbert & Berghoff LLP. All rights reserved. The information contained in this newsletter reflects the understanding and opinions of the author(s) and is provided to you for informational purposes only. It is not intended to and does not represent legal advice. MBHB LLP does not intend to create an attorney–client relationship by providing this information to you. The information in this publication is not a substitute for obtaining legal advice from an attorney licensed in your particular state. snippets may be considered attorney advertising in some states.